These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38786052)

  • 61. Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease.
    Tabrizi SJ; Ghosh R; Leavitt BR
    Neuron; 2019 Mar; 101(5):801-819. PubMed ID: 30844400
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Uncovering the Genetic and Molecular Features of Huntington's Disease in Northern Colombia.
    Ahmad M; Ríos-Anillo MR; Acosta-López JE; Cervantes-Henríquez ML; Martínez-Banfi M; Pineda-Alhucema W; Puentes-Rozo P; Sánchez-Barros C; Pinzón A; Patel HR; Vélez JI; Villarreal-Camacho JL; Pineda DA; Arcos-Burgos M; Sánchez-Rojas M
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003344
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Huntington's Disease and Diabetes: Chronological Sequence of its Association.
    Montojo MT; Aganzo M; González N
    J Huntingtons Dis; 2017; 6(3):179-188. PubMed ID: 28968242
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evidence for a predisposing background for CAG expansion leading to HTT mutation in a Chinese population.
    Ma M; Yang Y; Shang H; Su D; Zhang H; Ma Y; Liu Y; Tao D; Zhang S
    J Neurol Sci; 2010 Nov; 298(1-2):57-60. PubMed ID: 20864123
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic modifiers of Mendelian disease: Huntington's disease and the trinucleotide repeat disorders.
    Holmans PA; Massey TH; Jones L
    Hum Mol Genet; 2017 Oct; 26(R2):R83-R90. PubMed ID: 28977442
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.
    Gagnon KT; Pendergraff HM; Deleavey GF; Swayze EE; Potier P; Randolph J; Roesch EB; Chattopadhyaya J; Damha MJ; Bennett CF; Montaillier C; Lemaitre M; Corey DR
    Biochemistry; 2010 Nov; 49(47):10166-78. PubMed ID: 21028906
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stick-slip unfolding favors self-association of expanded HTT mRNA.
    O'Brien BM; Moulick R; Jiménez-Avalos G; Rajasekaran N; Kaiser CM; Woodson SA
    Nat Commun; 2024 Oct; 15(1):8738. PubMed ID: 39384800
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Small interfering RNAs based on huntingtin trinucleotide repeats are highly toxic to cancer cells.
    Murmann AE; Gao QQ; Putzbach WE; Patel M; Bartom ET; Law CY; Bridgeman B; Chen S; McMahon KM; Thaxton CS; Peter ME
    EMBO Rep; 2018 Mar; 19(3):. PubMed ID: 29440125
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Myricetin Reduces Toxic Level of CAG Repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs).
    Khan E; Tawani A; Mishra SK; Verma AK; Upadhyay A; Kumar M; Sandhir R; Mishra A; Kumar A
    ACS Chem Biol; 2018 Jan; 13(1):180-188. PubMed ID: 29172480
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oligonucleotides Targeting DNA Repeats Downregulate
    Umek T; Olsson T; Gissberg O; Saher O; Zaghloul EM; Lundin KE; Wengel J; Hanse E; Zetterberg H; Vizlin-Hodzic D; Smith CIE; Zain R
    Nucleic Acid Ther; 2021 Dec; 31(6):443-456. PubMed ID: 34520257
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intermediate and Expanded HTT Alleles and the Risk for α-Synucleinopathies.
    Pérez-Oliveira S; Álvarez I; Rosas I; Menendez-González M; Blázquez-Estrada M; Aguilar M; Corte D; Buongiorno M; Molina-Porcel L; Aldecoa I; Martí MJ; Sánchez-Juan P; Infante J; González-Aramburu I; García-González P; Rosende-Roca M; Boada M; Ruiz A; Periñán MT; Macías-García D; Muñoz-Delgado L; Gómez-Garre P; Mir P; Clarimón J; Lleo A; Alcolea D; De la Casa-Fages B; Duarte I; Álvarez V; Pastor P
    Mov Disord; 2022 Sep; 37(9):1841-1849. PubMed ID: 35852957
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enhanced Detection and Sizing of the HTT CAG Repeat Expansion in Huntington Disease Using an Improved Triplet-Primed PCR Assay.
    Zhao M; Lee CG; Law HY; Chong SS
    Neurodegener Dis; 2016; 16(5-6):348-51. PubMed ID: 27207688
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Translating Antisense Technology into a Treatment for Huntington's Disease.
    Lane RM; Smith A; Baumann T; Gleichmann M; Norris D; Bennett CF; Kordasiewicz H
    Methods Mol Biol; 2018; 1780():497-523. PubMed ID: 29856033
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The diagnosis and natural history of Huntington disease.
    Pagan F; Torres-Yaghi Y; Altshuler M
    Handb Clin Neurol; 2017; 144():63-67. PubMed ID: 28947126
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Robust Preimplantation Genetic Testing of Huntington Disease by Combined Triplet-Primed PCR Analysis of the HTT CAG Repeat and Multi-Microsatellite Haplotyping.
    Zhao M; Cheah FSH; Tan ASC; Lian M; Phang GP; Agarwal A; Chong SS
    Sci Rep; 2019 Nov; 9(1):16481. PubMed ID: 31712634
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice.
    Goula AV; Berquist BR; Wilson DM; Wheeler VC; Trottier Y; Merienne K
    PLoS Genet; 2009 Dec; 5(12):e1000749. PubMed ID: 19997493
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Attenuated huntingtin gene CAG nucleotide repeat size in individuals with Lynch syndrome.
    Dalene Skarping K; Arning L; Petersén Å; Nguyen HP; Gebre-Medhin S
    Sci Rep; 2024 Feb; 14(1):4300. PubMed ID: 38383663
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice.
    Kovalenko M; Dragileva E; St Claire J; Gillis T; Guide JR; New J; Dong H; Kucherlapati R; Kucherlapati MH; Ehrlich ME; Lee JM; Wheeler VC
    PLoS One; 2012; 7(9):e44273. PubMed ID: 22970194
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissues.
    Hoschek F; Natan J; Wagner M; Sathasivam K; Abdelmoez A; von Einem B; Bates GP; Landwehrmeyer GB; Neueder A
    Mol Med; 2024 Mar; 30(1):36. PubMed ID: 38459427
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lack of association of somatic CAG repeat expansion with striatal neurodegeneration in HD knock-in animal models.
    Bai D; Yin P; Zhang Y; Sun F; Chen L; Lin L; Yan S; Li S; Li XJ
    Hum Mol Genet; 2021 Jul; 30(16):1497-1508. PubMed ID: 33949657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.